Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 6:27 pm Purchase | 2024-09-30 | 13G | SI-BONE, Inc. SIBN | ORBIMED CAPITAL LLC | 3,249,500 7.800% | 944,200 (+40.96%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | ORBIMED CAPITAL LLC | 0 0.000% | -2,583,821 (Position Closed) | Filing History |
| 2023-02-14 4:14 pm Sale | 2022-12-31 | 13G | Cybin Inc. CYBN | ORBIMED CAPITAL LLC | 161,929 3.700% | -135,211 (-45.50%) | Filing History |
| 2022-02-11 4:44 pm Purchase | 2021-12-31 | 13G | SI-BONE, Inc. SIBN | ORBIMED CAPITAL LLC | 2,305,300 6.900% | 2,305,300 (New Position) | Filing History |
| 2022-02-11 4:32 pm Purchase | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | ORBIMED CAPITAL LLC | 2,583,821 8.700% | 90,712 (+3.64%) | Filing History |
| 2022-02-11 4:20 pm Purchase | 2021-12-31 | 13G | Cybin Inc. CYBN | ORBIMED CAPITAL LLC | 297,139 7.000% | 297,139 (New Position) | Filing History |
| 2022-02-11 4:15 pm Sale | 2021-12-31 | 13G | Aptose Biosciences Inc. APTO | ORBIMED CAPITAL LLC | 0 0.000% | -535,333 (Position Closed) | Filing History |
| 2021-02-12 5:03 pm Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | ORBIMED CAPITAL LLC | 2,493,109 8.360% | 2,493,109 (New Position) | Filing History |
| 2021-02-12 4:42 pm Purchase | 2020-12-31 | 13G | Aptose Biosciences Inc. APTO | ORBIMED CAPITAL LLC | 535,333 9.040% | 535,333 (New Position) | Filing History |
| 2020-02-14 12:00 pm Sale | 2019-12-31 | 13G | FOAMIX PHARMACEUTICALS LTD FOMX | ORBIMED CAPITAL LLC | 2,577,982 4.170% | -2,617,348 (-50.38%) | Filing History |